How Andreessen Horowitz competes for the best health tech startups – STAT

Biotech & Pharma
Health Tech
Politics
Health & Science
Team
Exclusive analysis of biotech, pharma, and the life sciences
Topics
Columns
Tools
Events
Team
Account
More
Follow Us
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Conversations series
hosted by STAT+, plus early-bird access and discounts to industry events around the country
get delivered to your inbox to brief you on the most important industry news of the day
like our CRISPR Trackr and Drug Pricing Policy Tracker
By Mario Aguilar Feb. 4, 2022
Since Julie Yoo joined Andreessen Horowitz as a general partner in 2019, investment in health care companies has skyrocketed. For entrepreneurs with more funding options than ever, Yoo’s experience breathing life into a startup of her own is a major selling point.
Yoo spent eight years at Kyruus, which she co-founded and where she served as chief product officer for its patient routing, provider matching, and appointment scheduling platform. CEOs of two companies Andreessen Horowitz funded in the last year told STAT that Yoo’s deep understanding of how to build a health care technology company makes her a compelling partner.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
Health Tech Correspondent
Mario covers how technology is transforming health care.




This name will appear with your comment
There was an error saving your display name. Please check and try again.
By Casey Ross
By Katie Palmer
advertisement
By Jonathan Wosen
By Adam Feuerstein, Damian Garde and Matthew Herper
By Casey Ross
Reporting from the frontiers of health and medicine

source